A monoclonal antibody that binds to LAG-3 on tumor infiltrating lymphocytes (TILs), with potential immune checkpoint inhibitory and antineoplastic activities. LAG-3 is a member of the immunoglobulin superfamily (IgSF) and binds to major histocompatibility complex (MHC) class II.